8 Recruiting Myelodysplastic Syndromes Clinical Trials in California
Explore active myelodysplastic syndromes research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceRecruiting Myelodysplastic Syndromes Studies in California
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
📍 Local Institution - 0070 — Clovis, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
📍 Innovative Clinical Research Institute Whittier — Lakewood, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
📍 Local Institution - 0051 — Los Alamitos, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve
📍 Local Institution - 107 — Berkeley, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
📍 Keck School of Medicine of USC — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
📍 University of California Davis Health (UC Davis Health) — Sacramento, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of REM-422 in Patients With AML or Higher Risk MDS
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
📍 City of Hope — Duarte, California
View Study & Checklist ➔